Samsara
Boston, US · 3 known investors
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
Investors · 3
Frequently asked questions
- What does Samsara do?
- Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
- Who are Samsara's investors?
- Samsara's investors include Apollo Health Ventures, CoastCap, Korify Capital.
- Where is Samsara headquartered?
- Samsara is headquartered in Boston, US.